rs149840356
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_033305.3(VPS13A):āc.4760A>Gā(p.Tyr1587Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00828 in 1,613,384 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_033305.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS13A | NM_033305.3 | c.4760A>G | p.Tyr1587Cys | missense_variant | 39/72 | ENST00000360280.8 | NP_150648.2 | |
VPS13A | NM_001018037.2 | c.4643A>G | p.Tyr1548Cys | missense_variant | 38/71 | NP_001018047.1 | ||
VPS13A | NM_015186.4 | c.4760A>G | p.Tyr1587Cys | missense_variant | 39/69 | NP_056001.1 | ||
VPS13A | NM_001018038.3 | c.4760A>G | p.Tyr1587Cys | missense_variant | 39/69 | NP_001018048.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00527 AC: 802AN: 152054Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00457 AC: 1149AN: 251150Hom.: 1 AF XY: 0.00476 AC XY: 646AN XY: 135726
GnomAD4 exome AF: 0.00860 AC: 12564AN: 1461212Hom.: 70 Cov.: 30 AF XY: 0.00833 AC XY: 6053AN XY: 726888
GnomAD4 genome AF: 0.00527 AC: 802AN: 152172Hom.: 3 Cov.: 32 AF XY: 0.00484 AC XY: 360AN XY: 74402
ClinVar
Submissions by phenotype
not provided Benign:5
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 14, 2018 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2024 | VPS13A: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 25, 2018 | - - |
Chorea-acanthocytosis Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 16, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at